Overdose deaths fall for 18th straight month, CDC estimates show

An estimated 65,724 Americans died of drug overdoses in the 12 months ending June 2026, according to the latest provisional estimates from the Centers for Disease Control and Prevention, highlighted Monday by the White House Office of National Drug Control Policy.

The drug policy office said that figure is about 41.5% below the peak of 112,418 and the lowest predicted provisional estimate since December 2016. It said overdose deaths have now declined for 18 straight months and every month since President Trump took office in January 2025.

What the data show

The CDC numbers are rolling 12-month totals. The latest window runs from July 1, 2025, through June 30, 2026. The 65,724 figure is a predicted count, which adjusts the deaths already reported for the delays that come with toxicology testing and death investigations. The CDC warns that provisional counts are subject to change and should not be treated as final data.

The drug policy office broke out the changes over the same 12-month period by drug type:

  • Synthetic opioids, including fentanyl: down 18.7%
  • Heroin: down 34.8%
  • Methamphetamine and other psychostimulants: down 14.1%
  • Cocaine: down 6.3%
  • Prescription and other natural or semi-synthetic opioids: down 5.4%

“This historic decline in drug overdose deaths demonstrates that America is unequivocally winning the fight against illicit drugs,” drug policy director Sara Carter said. She credited “President Trump’s common-sense policies, like securing our borders, dismantling and eliminating narco-terrorist organizations, and employing primary and early prevention efforts within our communities.”

Why it matters

Fentanyl has driven the overdose crisis, and the administration ties its border crackdown and its campaign against cartel networks directly to the falling death toll. The new estimate works out to about 46,700 fewer deaths over a 12-month span than at the peak.

Daily Beltway analysis: the largest declines are in heroin and synthetic opioid deaths, including fentanyl, the drugs at the center of the border fight. That fits the administration’s case, though the CDC data alone cannot show what caused the decline.

The other side

Researchers say the drop started before the current administration and has more than one cause. Greg Midgette and Peter Reuter of the University of Maryland wrote in a Brookings analysis that deaths “began to fall in mid-2023,” falling from about 110,000 in the 12 months ending June 2023 to about 72,000 by August 2025. They concluded the cause “is almost certainly some combination of supply-side changes, demand-side adaptation, and the hard-to-quantify effects of community organizations doing the daily work of harm reduction.”

The two researchers found that neither wider naloxone access nor the end of the X-waiver for prescribing buprenorphine produced changes big enough to explain the drop in fentanyl deaths. They pointed instead to changes in the drug supply, including more xylazine and more consistent pill composition, as possible factors.

What’s next

The CDC updates its provisional overdose counts every month. The next release will cover the 12 months ending July 2026 and will show whether the streak reaches 19 months.

Sources

If an embedded post does not load, these links open the originals.

Daily Beltway
Thomashttps://dailybeltway.com
Thomas is the editor of Daily Beltway, covering Congress, the White House and national politics. Daily Beltway's coverage is compiled from official releases, documents, on-record statements and other news reports, and every story is reviewed before publishing. Corrections: see our Editorial Standards page.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Read

The Daily Beltway Briefing

How we handle your email